Skip to content
Search

Latest Stories

US emerges as virus hotspot as infections, unemployment soar

The United States was quickly becoming a new epicenter of the global coronavirus pandemic on Thursday (26) as new infections soared and unemployment claims skyrocketed to a historic high.

Hospitals increasingly have reported being overwhelmed with COVID-19 cases and 40 percent of Americans are under lockdown orders, although a buoyant Wall Street recouped more of this month's massive losses as Congress moved forward on a $2 trillion rescue package.


More than 100 people died in the past day in virus hotbed New York, where a long line of people, most in masks and standing three feet (a meter) apart, snaked outside the Elmhurst hospital in Jackson Heights under police watch as they waited to be tested.

Governor Andrew Cuomo said the top priority was to "flatten the curve" of new cases as the New York City area tries to more than double its available number of hospital beds to 140,000.

"This is all about getting that curve down and not overwhelming the hospital system," Cuomo told reporters.

"Almost any scenario that is realistic will overwhelm the capacity of the current health care system," he warned.

Mayor Bill de Blasio said city hospitals in recent days have seen in influx of badly needed supplies from both the state and federal governments.

"That is a ray of light for sure," de Blasio said Wednesday.

"But we know we're going to have giant challenges ahead in terms of producing enough hospital space or enough personnel who are trained to help us in this crisis."

The number of deaths caused by the novel coronavirus reached the grim threshold of 1,000 by late Wednesday and on Thursday the country had 69,246 confirmed cases, according to a Johns Hopkins University database. New York accounts for 385 deaths.

The number of infections is just below hardest-affected Italy and China, where the virus was first detected last year in the metropolis of Wuhan.

While fatalities remain higher elsewhere, experts say new infection numbers show that more Americans will die -- and the true number of cases could be much higher than the official figure due to shortages of test kits.

- Unemployment skyrockets -

The pandemic has already, and rapidly, been catastrophic to the world's largest economy, which looks to be heading into a recession.

The Labor Department reported that 3.3 million people applied for unemployment benefits last week, by far the highest number ever recorded.

Job losses have been widespread across sectors including food services, accommodation, entertainment and transportation, according to the normally routine report.

The US Congress, which is usually deeply polarized, has come together in the face of the crisis after negotiations between President Donald Trump's Republicans and rival Democrats.

The Senate overnight unanimously passed a $2 trillion package -- the largest stimulus in US history, which will provide cash payouts that average $3,400 for an average family of four.

The bill heads Friday to the Democratic-led House of Representatives, where leaders of both parties have urged passage.

"It will pass and will pass with strong bipartisan support," House Speaker Nancy Pelosi told reporters.

"We will have a victory tomorrow for America's workers."

Wall Street's benchmark Dow Jones index had soared more than five percent in late-morning trade, although it was still far down from this year's highs.

Many market players hope COVID-19 will be a short-term challenge followed by a strong recovery -- a view avidly shared by Trump, who has banked on a strong economy as he seeks re-election in November.

Trump has voiced hope that normal life can resume by mid-April, a goal that many health experts say is unrealistic and jars with moves from Europe to India to keep people indoors to stem the virus, known formally as SARS-CoV-2.

But top US scientist Anthony Fauci warned that the virus could become a regular occurrence -- making the international race for a vaccine even more pressing.

He said that the disease was beginning to take root in countries in the southern hemisphere, where winter is on the way.

"And if, in fact, they have a substantial outbreak, it will be inevitable that we need to be prepared that we'll get a cycle around the second time," said Fauci, who leads research into infectious diseases at the National Institutes of Health.

"It totally emphasizes the need to do what we're doing in developing a vaccine, testing it quickly and trying to get it ready so that we'll have a vaccine available for that next cycle," he told reporters.

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less